Published in Clin J Am Soc Nephrol on June 10, 2010
Predictors of outpatient kidney function recovery among patients who initiate hemodialysis in the hospital. Am J Kidney Dis (2014) 1.52
Phosphate control in end-stage renal disease: barriers and opportunities. Nephrol Dial Transplant (2013) 1.46
Vascular access in haemodialysis: strengthening the Achilles' heel. Nat Rev Nephrol (2013) 1.09
Improving incident fistula rates: a process of care issue. Am J Kidney Dis (2011) 0.88
Why multidisciplinary clinics should be the standard for treating chronic kidney disease. Pediatr Nephrol (2012) 0.88
Impact of hemodialysis on dyspnea and lung function in end stage kidney disease patients. Biomed Res Int (2014) 0.81
Controversies in timing of dialysis initiation and the role of race and demographics. Semin Dial (2013) 0.78
Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med (2006) 17.55
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med (2009) 14.13
Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med (2006) 10.65
Inequality in quality: addressing socioeconomic, racial, and ethnic disparities in health care. JAMA (2000) 10.51
The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood (2005) 5.58
The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med (2002) 5.33
Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol (2006) 3.84
Hematologic differences between African-Americans and whites: the roles of iron deficiency and alpha-thalassemia on hemoglobin levels and mean corpuscular volume. Blood (2005) 3.77
Vascular access use and outcomes: an international perspective from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant (2008) 2.99
Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol (2005) 2.79
Impact of quality improvement efforts on race and sex disparities in hemodialysis. JAMA (2003) 2.77
Late nephrology referral and mortality among patients with end-stage renal disease: a propensity score analysis. Nephrol Dial Transplant (2004) 2.55
Treatment center and geographic variability in pre-ESRD care associate with increased mortality. J Am Soc Nephrol (2009) 2.21
Prevalence, predictors, and consequences of late nephrology referral at a tertiary care center. J Am Soc Nephrol (1999) 1.92
National profile of practice patterns for hemodialysis vascular access in the United States. J Am Soc Nephrol (2002) 1.79
A propensity analysis of late versus early nephrologist referral and mortality on dialysis. J Am Soc Nephrol (2003) 1.78
Comparison of causes of death using HEMO Study and HCFA end-stage renal disease death notification classification systems. The National Institutes of Health-funded Hemodialysis. Health Care Financing Administration. Am J Kidney Dis (2002) 1.63
Prevalence of and factors associated with suboptimal care before initiation of dialysis in the United States. J Am Soc Nephrol (1999) 1.49
Relationship between clinical performance measures and outcomes among patients receiving long-term hemodialysis. Ann Intern Med (2006) 1.25
Which targets in clinical practice guidelines are associated with improved survival in a large dialysis organization? J Am Soc Nephrol (2007) 1.15
Attainment of clinical performance targets and improvement in clinical outcomes and resource use in hemodialysis care: a prospective cohort study. BMC Health Serv Res (2007) 1.08
Laboratory abnormalities at the onset of treatment of end-stage renal disease: are there racial or socioeconomic disparities in care? Arch Intern Med (2007) 1.07
Possible effects of the new Medicare reimbursement policy on African Americans with ESRD. J Am Soc Nephrol (2009) 0.97
Gender differences in vascular access in hemodialysis patients in the United States: developing strategies for improving access outcome. Gend Med (2007) 0.92
Improving the care of ESRD patients: a success story. Health Care Financ Rev (2003) 0.91
Associations with predialysis vascular access management. Am J Kidney Dis (2004) 0.91
Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older men. Contemp Clin Trials (2005) 9.57
Age and association of kidney measures with mortality and end-stage renal disease. JAMA (2012) 7.20
Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol (2008) 6.91
Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol (2006) 6.86
'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis (2012) 5.70
Lasofoxifene in postmenopausal women with osteoporosis. N Engl J Med (2010) 5.60
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int (2011) 5.47
The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Ann Intern Med (2005) 5.45
Cancer after kidney transplantation in the United States. Am J Transplant (2004) 5.08
Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol (2004) 4.79
BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res (2003) 4.64
Long interdialytic interval and mortality among patients receiving hemodialysis. N Engl J Med (2011) 4.62
Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial. J Am Soc Nephrol (2006) 3.51
Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis (2008) 3.34
An improved comorbidity index for outcome analyses among dialysis patients. Kidney Int (2009) 3.32
Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med (2007) 3.27
Excerpts from the US Renal Data System 2009 Annual Data Report. Am J Kidney Dis (2010) 3.11
Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med (2002) 3.10
US Renal Data System 2010 Annual Data Report. Am J Kidney Dis (2011) 2.90
Uric acid and long-term outcomes in CKD. Am J Kidney Dis (2009) 2.86
Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States. Am J Kidney Dis (2005) 2.81
Differences in diabetes prevalence, incidence, and mortality among the elderly of four racial/ethnic groups: whites, blacks, hispanics, and asians. Diabetes Care (2004) 2.80
Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol (2005) 2.79
End-stage renal disease in the United States: an update from the United States Renal Data System. J Am Soc Nephrol (2007) 2.73
Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med (2007) 2.71
US Renal Data System 2013 Annual Data Report. Am J Kidney Dis (2014) 2.68
Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol (2008) 2.65
The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int (2004) 2.63
CKD: common, harmful, and treatable--World Kidney Day 2007. Am J Kidney Dis (2007) 2.58
Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med (2003) 2.54
US Renal Data System 2012 Annual Data Report. Am J Kidney Dis (2013) 2.54
Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study. J Am Soc Nephrol (2005) 2.51
Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study. Kidney Int (2005) 2.45
Impact of the clinical conditions at dialysis initiation on mortality in incident haemodialysis patients: a national cohort study in Taiwan. Nephrol Dial Transplant (2010) 2.45
The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis. Clin J Am Soc Nephrol (2009) 2.41
Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study. Kidney Int (2002) 2.36
Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J (2008) 2.35
The association of initial hemodialysis access type with mortality outcomes in elderly Medicare ESRD patients. Am J Kidney Dis (2003) 2.30
Reduced renal function and sleep-disordered breathing in community-dwelling elderly men. Sleep Med (2008) 2.26
Chronic kidney disease and cardiovascular disease in the Medicare population. Kidney Int Suppl (2003) 2.20
Excerpts from the United States Renal Data System 2006 Annual Data Report. Am J Kidney Dis (2007) 2.16
United States Renal Data System 2008 Annual Data Report. Am J Kidney Dis (2009) 2.14
Hypertension awareness, treatment, and control in chronic kidney disease. Am J Med (2008) 2.11
Issues regarding 'immortal time' in the analysis of the treatment effects in observational studies. Kidney Int (2011) 2.10
A comparison of peritonitis rates from the United States Renal Data System database: CAPD versus continuous cycling peritoneal dialysis patients. Am J Kidney Dis (2005) 2.09
Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J Am Soc Nephrol (2010) 2.08
Survival in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients. J Am Soc Nephrol (2012) 2.03
Excerpts from the United States Renal Data System 2007 annual data report. Am J Kidney Dis (2008) 2.01
Hemoglobin level variability: associations with comorbidity, intercurrent events, and hospitalizations. Clin J Am Soc Nephrol (2006) 2.01
Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data. BMJ (2009) 2.00
Cardiovascular risk factor profiles and kidney function stage in the US general population: the NHANES III study. Mayo Clin Proc (2005) 1.96
Consensus statement: Palliative and supportive care in advanced heart failure. J Card Fail (2004) 1.95
C-reactive protein in heart failure: prognostic value and the effect of valsartan. Circulation (2005) 1.92
Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation (2002) 1.91
Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial. J Bone Miner Res (2007) 1.88
Dose-dependent effect of statins on the incidence of acute kidney injury after cardiac surgery. Ann Thorac Surg (2011) 1.85
Factors associated with kyphosis progression in older women: 15 years' experience in the study of osteoporotic fractures. J Bone Miner Res (2013) 1.84
Effect of comorbidity on the increased mortality associated with early initiation of dialysis. Am J Kidney Dis (2005) 1.84
Factors associated with the lumbar spine and proximal femur bone mineral density in older men. Osteoporos Int (2005) 1.82
Atrial fibrillation and stroke in the general medicare population: a 10-year perspective (1992 to 2002). Stroke (2006) 1.76
Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) conference. Clin J Am Soc Nephrol (2008) 1.76
Long-term cognitive and functional effects of potentially inappropriate medications in older women. J Gerontol A Biol Sci Med Sci (2013) 1.74
Finite element analysis of the proximal femur and hip fracture risk in older men. J Bone Miner Res (2009) 1.73
Associations between body composition, anthropometry, and mortality in women aged 65 years and older. Am J Public Health (2007) 1.72
CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis (2008) 1.71
A comparison of transplant outcomes in peritoneal and hemodialysis patients. Kidney Int (2002) 1.71
The relationship between bisphosphonate adherence and fracture: is it the behavior or the medication? Results from the placebo arm of the fracture intervention trial. J Bone Miner Res (2011) 1.70
Septicemia in the United States dialysis population, 1991 to 1999. J Am Soc Nephrol (2004) 1.70